Methods: Double blinded, randomized controlled trial with 1:1 allocation of mifepristone or
placebo at initiation of induction of labor for fetal demise 20 weeks estimated gestational
age or greater.
Hypothesis: Mifepristone will expedite time to delivery of fetus among demise patients, when
compared to placebo, and in conjunction with other pharmacologic methods for induction of
labor.
Expected outcomes: The addition of a progesterone receptor modulator will expedite time to
delivery of the fetus and ultimately improve the experience associated with induction of
labor for fetal demise.